M-M-R™ II

BIOLOGICAL2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Pneumococcal InfectionsVaricella

Phase 3

A Study to Evaluate the Immunogenicity, Safety, and Tolerability of VARIVAX™ Manufactured With a New Process (V210-062)

WithdrawnNCT01626794

Merck Sharp & Dohme LLCVaricella

Start: 2014-07-31End: 2015-10-31Updated: 2015-01-27

A Study to Evaluate the Interchangeability of V114 and Prevnar 13™ in Healthy Infants (V114-027/PNEU-DIRECTION)

CompletedNCT03620162

Merck Sharp & Dohme LLCPneumococcal Infections

Start: 2018-10-18End: 2020-12-14Updated: 2023-01-17

Related Papers

A phase 3, multicenter, randomized, double-blind study to evaluate the interchangeability of V114, a 15-valent pneumococcal conjugate vaccine, and PCV13 with respect to safety, tolerability, and immunogenicity in healthy infants (PNEU-DIRECTION).

2022-12-1312 citations